Latest Texas News

Metallium has completed a 12-hour campaign using three Flash Joule Heating reactors to process platinum-group-metal-bearing catalytic converter material under reactive chlorination conditions. The milestone advances the company’s scale-up program, but recovery results, product economics and feedstock grades remain unverified.

Helios Energy has posted a A$23.1 million FY2026 loss after writing off A$21.35 million in exploration assets. Its Presidio project retains a 17.5 million-barrel-of-oil-equivalent 2C contingent resource estimate, but the company warns that continued operations depend on further funding.

Eden Innovations has transformed its balance sheet, cutting interest-bearing liabilities from $16.97 million to negligible levels after year-end. But revenue fell 19%, the Group remained deeply loss-making and its auditor flagged a material uncertainty over going concern.

Metallium has moved Flash Joule Heating from tiny laboratory tests to multi-reactor campaigns in Texas, backed by feedstock contracts, offtake and A$125 million raised during FY2026. Yet the ASX-listed group remains pre-revenue, lost A$42.8 million and says continued access to funding is a material uncertainty.

Impact Minerals’ 50%-owned Alluminous project reveals a strong financial case for a staged US high purity alumina plant, projecting a post-tax NPV₈ of A$518 million and a 42.3% IRR under a modular development approach.

Lithium Universe’s Pre-Feasibility Study for its Brownsville Lithium Carbonate Refinery reveals robust economics and strategic US positioning, aiming to close North America’s lithium conversion gap.

Galilee Energy posted a $5.42 million loss for FY2026 amid heavy investment in its US Zydeco Gas Project and progressing the sale of its Australian Glenaras asset. The company is pivoting to US operations with drilling underway and a $3.5 million placement announced.

Eden Innovations Ltd trimmed its loss to $5 million in FY2026 while erasing bank debt and converting loans into equity, supported by property sales and capital raises.

Island Pharmaceuticals has obtained regulatory rights to reference critical Marburg-Angola virus natural history data, clearing a significant FDA hurdle for its antiviral Galidesivir. This milestone accelerates the path toward pivotal animal studies and potential FDA approval under the Animal Rule.

xReality Group (ASX: XRG) delivered a standout FY26 with total income up 43% to $20 million and EBITDA surging to $3.8 million, backed by rapid expansion of its Operator XR defence training platform.

Black Bear Minerals (ASX: BKB) has raised $12.5 million through a placement at a 16% discount to fund underground drilling and resource validation at its Shafter Silver Project in Texas, signaling strong institutional support for advancing mine restart plans.

Weebit Nano surged to record revenue of $15.3 million in FY26, fueled by key licensing deals and product tape-outs, while investing heavily in R&D and AI initiatives. Despite a $54.9 million loss, a $102 million capital raise leaves the company well-positioned for growth.